arimoclomol has been researched along with trypsinogen in 1 studies
| Studies (arimoclomol) | Trials (arimoclomol) | Recent Studies (post-2010) (arimoclomol) | Studies (trypsinogen) | Trials (trypsinogen) | Recent Studies (post-2010) (trypsinogen) |
|---|---|---|---|---|---|
| 34 | 4 | 22 | 1,963 | 20 | 297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boros, I; Iványi, B; Jednákovits, A; Lonovics, J; Németh, I; Rakonczay, Z; Takács, T; Varga, I | 1 |
1 other study(ies) available for arimoclomol and trypsinogen
| Article | Year |
|---|---|
Nontoxic heat shock protein coinducer BRX-220 protects against acute pancreatitis in rats.
Topics: Acute Disease; Amylases; Animals; Blotting, Western; Catalase; Chaperonin 60; Glutathione; Glutathione Peroxidase; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Hydroxylamines; Lipase; Lipid Peroxidation; Male; Pancreas; Pancreatitis; Rabbits; Rats; Rats, Wistar; Sincalide; Superoxide Dismutase; Trypsinogen | 2002 |